Skip to content

GHRP-2 studies: 202 papers with results

Page 2 of 5

  1. Evaluation of Hypothalamic-Pituitary-Adrenal Axis by the GHRP2 Test: Comparison With the Insulin Tolerance Test.

    Hayakawa T · Journal of the Endocrine Society · 2018

    Observational study · 6 results

  2. ODP323 Increased Serum High-Sensitivity C-Reactive Protein Levels in Adult Growth Hormone Deficient Patients with Non-Functioning Pituitary Tumors

    Journal of the Endocrine Society · 2022

    Observational study · 4 results

  3. Association between overweight and growth hormone secretion in patients with non-functioning pituitary tumors.

    Seki Y · PloS one · 2022

    Observational study · 7 results

  4. The arginine and GHRP-2 tests as alternatives to the insulin tolerance test for the diagnosis of adult GH deficiency in Japanese patients: a comparison.

    Kinoshita Y · Endocrine journal · 2013

    Observational study · 2 results

  5. Assessment of anterior pituitary reserve capacity based on growth hormone response to growth hormone-releasing peptide-2 test in the elderly.

    Teramoto S · Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 2023

    Observational study · 5 results

  6. Clinical Usefulness of the Growth Hormone-Releasing Peptide-2 Test for Hypothalamic-Pituitary Disorder.

    Suzuki S · Journal of the Endocrine Society · 2022

    Observational study · 7 results

  7. LBODP006 Clinical Usefulness Of The Growth Hormone-releasing Peptide-2 Test For Hypothalamic-pituitary Disorder

    Journal of the Endocrine Society · 2022

    Observational study · 7 results

  8. Comparison of pituitary-adrenal responsiveness between insulin tolerance test and growth hormone-releasing peptide-2 test: a pilot study.

    Kano T · Peptides · 2010

    Observational study · 5 results

  9. Robust growth hormone responses to GH-releasing peptide 2 in adolescents.

    Onuki T · Journal of pediatric endocrinology & metabolism : JPEM · 2024

    Observational study · 4 results

  10. Diagnostic usefulness of the growth hormone-releasing peptide-2 test as a substitute for the insulin tolerance test in hypopituitarism.

    Kageyama K · Endocrine journal · 2008

    Observational study · 2 results

  11. Possible Involvement of Hypothalamic Dysfunction in Long COVID Patients Characterized by Delayed Response to Gonadotropin-Releasing Hormone.

    Otsuka Y · International journal of molecular sciences · 2026

    Observational study · 1 result

  12. Differentiating hypothalamic from pituitary adrenal insufficiency: underlying causes and diagnostic utility of the corticotropin-releasing hormone and growth hormone-releasing peptide-2 stimulation tests.

    Okada N · Endocrine journal · 2026

    Observational study · 1 result

  13. Benchmark for Setting ACTH Cell Dosage in Clinical Regenerative Medicine for Post-Operative Hypopituitarism.

    Kondo T · Diseases (Basel, Switzerland) · 2025

    Observational study · 1 result

  14. Concordant and discordant adrenocorticotropin (ACTH) responses induced by growth hormone-releasing peptide-2 (GHRP-2), corticotropin-releasing hormone (CRH) and insulin-induced hypoglycemia in patients with hypothalamopituitary disorders: evidence for direct ACTH releasing activity of GHRP-2.

    Kimura T · Endocrine journal · 2010

    Case report or series · 1 result

  15. Evaluation of growth hormone-releasing peptide-2 for diagnosis of thyrotropin-producing pituitary adenomas.

    Kageyama K · Endocrine journal · 2018

    Case report or series · 3 results

  16. One-year intranasal application of growth hormone releasing peptide-2 improves body weight and hypoglycemia in a severely emaciated anorexia nervosa patient.

    Haruta I · Journal of cachexia, sarcopenia and muscle · 2015

    Case report or series · 8 results

  17. Exaggerated response of adrenocorticotropic hormone to growth hormone-releasing peptide-2 test in Cushing's disease. Case report.

    Sakihara S · Neurologia medico-chirurgica · 2009

    Case report or series · 2 results

  18. Is there an undiscovered neurocircuit for regulating GH secretion? -Pitfalls of GHRP-2 and ITT as GH provocative tests-.

    Kamoi K · Endocrine journal · 2010

    Case report or series · 1 result

  19. GH releasing peptides--structure and kinetics.

    Bowers CY · The Journal of pediatric endocrinology · 1993

    Other design · 6 results

  20. Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry.

    Thomas A · Analytical and bioanalytical chemistry · 2011

    Other design · 9 results

  21. Structure-activity relationship for peptídic growth hormone secretagogues.

    Ferro P · Drug testing and analysis · 2017

    Other design · 7 results

  22. Physiologically based pharmacokinetic model for pralmorelin hydrochloride in rats.

    Nasu R · Drug metabolism and disposition: the biological fate of chemicals · 2005

    Animal study (in vivo) · rat · 3 results

  23. Tissue deiodinase activity during prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone-releasing peptide-2.

    Debaveye Y · Endocrinology · 2005

    Animal study (in vivo) · rabbit · 5 results

  24. Pretreatment with growth hormone-releasing peptide-2 directly protects against the diastolic dysfunction of myocardial stunning in an isolated, blood-perfused rabbit heart model.

    Weekers F · Endocrinology · 2000

    Animal study (in vivo) · rabbit · 6 results

  25. Characteristics of growth hormone secretion responsiveness to growth hormone-releasing peptide-2 (GHRP-2 or KP102) in calves.

    Roh SG · Endocrine journal · 1996

    Animal study (in vivo) · cattle (holstein calves) · 8 results

  26. Effects of dietary protein and growth hormone-releasing peptide (GHRP-2) on plasma IGF-1 and IGFBPs in Holstein steers.

    Lee HG · Domestic animal endocrinology · 2005

    Animal study (in vivo) · cattle (holstein steers) · 6 results

  27. The effect of growth hormone-releasing peptide-2 (KP102) administration on plasma insulin-like growth factor (IGF)-1 and IGF-binding proteins in Holstein steers on different planes of nutrition.

    Lee HG · Domestic animal endocrinology · 2000

    Animal study (in vivo) · cattle · 8 results

  28. Diurnal and Daily Variations in Growth Hormone and Growth Hormone Stimulation Test in Male Cynomolgus Monkeys.

    Taniguchi Y · In vivo (Athens, Greece) · 2026

    Animal study (in vivo) · cynomolgus monkey · 2 results

  29. Effects of the administration of growth hormone-releasing peptide-2 (GHRP-2) orally by gavage and in feed on growth hormone release in swine.

    Phung LT · Domestic animal endocrinology · 2001

    Animal study (in vivo) · swine · 8 results

  30. Effects of GHRP-2 and Cysteamine Administration on Growth Performance, Somatotropic Axis Hormone and Muscle Protein Deposition in Yaks (Bos grunniens) with Growth Retardation.

    Hu R · PloS one · 2016

    Animal study (in vivo) · yak (bos grunniens) · 6 results

  31. The effect of growth hormone releasing peptide-2 on upper gastrointestinal contractile activity and food intake in conscious dogs.

    Kudoh K · Journal of gastroenterology · 2009

    Animal study (in vivo) · dog · 6 results

  32. No desensitization of the growth hormone (GH) response between GH-releasing peptide-2 and GH-releasing factor in calves.

    Roh SG · Journal of animal science · 1997

    Animal study (in vivo) · calf · 4 results

  33. Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats.

    Granado M · American journal of physiology. Endocrinology and metabolism · 2005

    Animal study (in vivo) · rat · 8 results

  34. GH-releasing peptide-2 increases fat mass in mice lacking NPY: indication for a crucial mediating role of hypothalamic agouti-related protein.

    Tschöp M · Endocrinology · 2002

    Animal study (in vivo) · mouse · 9 results

  35. Chicken ghrelin and growth hormone-releasing peptide-2 inhibit food intake of neonatal chicks.

    Saito ES · European journal of pharmacology · 2002

    Animal study (in vivo) · chicken (neonatal chicks) · 1 result

  36. Endocrine and orexigenic actions of growth hormone secretagogues in rainbow trout (Oncorhynchus mykiss).

    Shepherd BS · Comparative biochemistry and physiology. Part A, Molecular & integrative physiology · 2007

    Animal study (in vivo) · rainbow trout (oncorhynchus mykiss) · 7 results

  37. Ipamorelin, the first selective growth hormone secretagogue.

    Raun K · European journal of endocrinology · 1998

    Animal study (in vivo) · swine · 23 results

  38. Intracerebroventricular administration of the growth hormone-releasing peptide KP-102 increases food intake in free-feeding rats.

    Okada K · Endocrinology · 1996

    Animal study (in vivo) · rat · 4 results

  39. Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle.

    Granado M · American journal of physiology. Endocrinology and metabolism · 2005

    Animal study (in vivo) · rat · 9 results

  40. Metabolism of growth hormone releasing peptides.

    Thomas A · Analytical chemistry · 2012

    Animal study (in vivo) · rat · 5 results

  41. β1-adrenergic receptors mediate plasma acyl-ghrelin elevation and depressive-like behavior induced by chronic psychosocial stress.

    Gupta D · Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019

    Animal study (in vivo) · mouse · 1 result

  42. GH-releasing peptide-2 administration prevents liver inflammatory response in endotoxemia.

    Granado M · American journal of physiology. Endocrinology and metabolism · 2008

    Animal study (in vivo) · rat · 9 results

  43. GHRP-2, a GHS-R agonist, directly acts on myocytes to attenuate the dexamethasone-induced expressions of muscle-specific ubiquitin ligases, Atrogin-1 and MuRF1.

    Yamamoto D · Life sciences · 2008

    Animal study (in vivo) · rat · 8 results

  44. The hexapeptide KP-102 (D-ala-D-beta-Nal-ala-trp-D-phe-lys-NH(2)) stimulates growth hormone release in a cichlid fish (Ooreochromis mossambicus).

    Shepherd BS · The Journal of endocrinology · 2000

    Animal study (in vivo) · tilapia (oreochromis mossambicus) · 2 results

  45. Growth hormone releasing peptide-2, a ghrelin agonist, attenuates lipopolysaccharide-induced acute lung injury in rats.

    Li G · The Tohoku journal of experimental medicine · 2010

    Animal study (in vivo) · rat (sprague-dawley and male) · 8 results

  46. Development of an enzyme-linked immunosorbent assay for the measurement of plasma growth hormone (GH) levels in channel catfish (Ictalurus punctatus): assessment of environmental salinity and GH secretogogues on plasma GH levels.

    Drennon K · General and comparative endocrinology · 2003

    Animal study (in vivo) · channel catfish · 1 result

  47. Ghrelin receptor agonist, GHRP-2, attenuates burn injury-induced MuRF-1 and MAFbx expression and muscle proteolysis in rats.

    Sheriff S · Peptides · 2009

    Animal study (in vivo) · rat · 5 results

  48. Regulation of ghrelin gene expression in stomach and feeding response to a ghrelin analogue in two strains of rats.

    Liu X · Peptides · 2004

    Animal study (in vivo) · rat · 4 results

  49. A 6-day intracerebroventricular infusion of the growth hormone-releasing peptide KP-102 stimulates food intake in both non-stressed and intermittently-stressed rats.

    Kuriyama H · Neuroscience letters · 2000

    Animal study (in vivo) · rat · 4 results

  50. Growth hormone-releasing peptide-2 suppresses vascular oxidative stress in ApoE-/- mice but does not reduce atherosclerosis.

    Titterington JS · Endocrinology · 2009

    Animal study (in vivo) · mouse · 11 results

How PepBank reports evidence